Literature DB >> 6345380

Effect of human leukocyte extracts and gingival exudate on periodontopathic bacteria.

M N Sela.   

Abstract

The effect of leukocyte hydrolytic enzymes on periodontopathic bacteria was examined in vitro. A frozen and thawed extract of human peripheral blood leukocytes (LE) and human gingival crevicular exudate (GE) were shown to be able to cause the release of 50% of the radioactivity from a leukotoxic strain of Actinobacillus actinomycetemcomitans (Aa Y4), labeled by 14C. A nonleukotoxic strain (Aa 653) was shown to be more susceptible to both LE and GE, up to 68% of the total radioactivity was solubilized by LE at pH 7.4. Both bacterial strains were found to be resistant to the activity of lysozyme, but highly susceptible to lysolecithin and mixtures of lysolecithin and lysozyme or LE. Capnocytophaga sputigena strain 4 was also found to be partially susceptible to the effect of LE and GE. The possible role of leukocyte hydrolytic enzymes in bacteriolysis and release of bacterial products in relation to periodontal disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345380     DOI: 10.1007/bf00917824

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

1.  Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism.

Authors:  C C Tsai; W P McArthur; P C Baehni; B F Hammond; N S Taichman
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

2.  Lysis of gram-negative organisms and the role of versene.

Authors:  R REPASKE
Journal:  Biochim Biophys Acta       Date:  1958-11

3.  The effect of leukocyte hydrolases on bacteria. XII. The release of lipopolysaccharide (LPS) from Salmonella typhi by leukocyte extracts, lysozyme, inflammatory exudates and by serum and synovial fluid and the modulation by anionic and cationic polyelectrolytes of LPS release and the sensitization of erythrocytes.

Authors:  M Ferne; Z Duchan; S Rabinowitz-Begner; M N Sela; I Ginsburg
Journal:  Inflammation       Date:  1978-03       Impact factor: 4.092

4.  Effect of leukocyte hydrolases on bacteria. I. Degradation of 14C-labeled Streptococcus and Staphylococcus by leukocyte lysates in vitro.

Authors:  M Lahav; N Ne'eman; E Adler; I Ginsburg
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

5.  Bacteriolytic activity of human gingival exudate.

Authors:  M N Sela; G Natan; M Lahav; I Ginsburg; T Dishon
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

6.  Comparative ultrastructure of leukotoxic and non-leukotoxic strains of Actinobacillus actinomycetemcomitans.

Authors:  C H Lai; M A Listgarten; B F Hammond
Journal:  J Periodontal Res       Date:  1981-07       Impact factor: 4.419

7.  A neutrophil disorder induced by capnocytophaga, a dental micro-organism.

Authors:  S B Shurin; S S Socransky; E Sweeney; T P Stossel
Journal:  N Engl J Med       Date:  1979-10-18       Impact factor: 91.245

8.  The effect of leukocyte hydrolases on bacteria : V. Modification of bacteriolysis by antiinflammatory agents and by cationic and anionic polyelectrolytes.

Authors:  M N Sela; M Lahav; N Ne'eman; Z Duchan; I Ginsburg
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

9.  Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.

Authors:  J Weiss; S Beckerdite-Quagliata; P Elsbach
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Leukotoxicity of an extract from Actinobacillus actinomycetemcomitans for human gingival polymorphonuclear leukocytes.

Authors:  N S Taichman; J M Wilton
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

View more
  1 in total

1.  Ultrastructural studies of the effect of human leukocyte extracts on periodontopathic bacteria.

Authors:  M N Sela; H Romano
Journal:  Inflammation       Date:  1983-06       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.